Cite Filings / NRIX / 0000080255-21-001444
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SC 13G

Amended Statement of Ownership

Nurix Therapeutics, Inc. · Filed 2021-08-10 · Acc 0000080255-21-001444

Documents 1

  • SC 13G Amended Statement of Ownership , nrix13gjul21.txt

Around this filing

  • 2022-02-04 SC 13G Amended Statement of Ownership
  • 2021-08-11 4 General Counsel sold 1,200 shares at $29.87 ($35,845)
  • 2021-08-11 4 Chief Business Officer sold 7,500 shares at an average $29.86 ($223,926)
  • 2021-08-10 SC 13G Amended Statement of Ownership
  • 2021-08-04 S-3ASR Registration Statement
  • 2021-08-03 4 Chief Scientific Officer sold 400 shares at $31.21 ($12,484)
  • 2021-02-16 SC 13G Amended Statement of Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · Perceptive Advisors LLC 4.9%
  2. 2026-11-16 SCHEDULE 13G/A · Deep Track Capital, LP 5.49%
  3. 2026-11-16 SCHEDULE 13G/A · Rubric Capital Management LP 4.55%
  4. 2026-11-16 SCHEDULE 13G/A · Vestal Point Capital, LP 6.4%
  5. 2026-11-16 SCHEDULE 13G/A · T. Rowe Price Associates, Inc. 4.4%
Loading nrix13gjul21.txt…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…